Tester Construction Gives is located in Bala Cynwyd, PA. According to its NTEE Classification (H12) the organization is classified as: Fund Raising & Fund Distribution, under the broad grouping of Medical Research and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Tester Construction Gives is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
TCGIVES WAS BORN IN MEMORY OF KATHLEEN K. SCHOEMAKER WHO LOST HER BATTLE TO PANCREATIC CANCER IN 2006. TCGIVES WILL RAISE MONEY TO PROMOTE PROGRESS IN THE DIAGNOSIS AND TREATMENT OF PANCREATIC CANCER IN HONOR OF KATHLEEN. EVERY YEAR, MORE THAN 62,000 AMERICANS ARE DIAGNOSED WITH PANCREATIC CANCER, THE THIRD-LEADING CAUSE OF CANCER DEATH IN THE COUNTRY. THROUGH FUNDRAISING EFFORTS TCGIVES, IN PARTNERSHIP WITH JEFFERSON'S SIDNEY KIMMEL CANCER CENTER, WANT TO GIVE THE GIFT OF HOPE TO PATIENTS AND FAMILIES MET WITH A DIAGNOSIS OF PANCREATIC CANCER.
Describe the Organization's Program Activity:
Part 3 - Line 4a
WE ARE AND CONTINUE TO BE OVERWHELMED BY DR. YEO'S TEAMS DEDICATION TO THEIR PATIENTS, THEIR FOCUS ON IMPROVING THEIR PATIENTS QUALITY OF LIFE, AND THEIR COMMITMENT TO FINDING A CURE TO PANCREATIC CANCER. TCG GIVES HAS PARTNERED WITH DR. YEO'S TEAM AND JEFFERSON'S SIDNEY KIMMEL CANCER CENTER THAT WE MAY ADVANCE TREATMENT OPTIONS FOR THOSE DIAGNOSED WITH PANCREATIC CANCER. THIS INITIATIVE SEEKS TO IDENTIFY BIOMARKERS IN EARLY STAGE TUMORS, WHICH CAN IN TURN INFORM TUMOR-SPECIFIC TREATMENT AND POTENTIALLY PREDICT DRUG REPSONSE AND DISEASE RECURRENCE. BIOMARKER TESTING IS NOT COVERED UNDER INSURANCE AND RELIES COMPLETELY ON DONATIONS FROM ORGANIZATIONS LIKE TCG GIVES. THIS RESEARCH WILL ADVANCE PANCREATIC CANCER TREATMENT AND IMPROVE SURVIVAL RATES, UTLIMATELY PROVIDING THE BIGGEST GIFT TO THOSE FACED WITH PANCREATIC CANCER: HOPE. JEFFERSON HAS THE TOP PANCREATIC SURGICAL AND RESEARCH TEAM IN THE COUNTRY, LED BY DR. CHARLES YEO. TCG GIVES PROCEEDS WILL GO DIRECTLY TO DR. YEO'S MOLECULAR PROFILING INITIATIVE. ONE OF THE GOALS OF JEFFERSONS' RESEARCH IS TO PROFILE EACH PATIENT'S TUMOR. AS DESCRIBED BY DR. YEO. "BY PROFILING EACH PATIENT'S TUMOR, WE CAN BETTER TARGET THEIR SPECIFIC CANCER. THIS IS THE DIRECTION OF MODERN, PERSONALIZED ONCOLOGIC CARE, NOT TO MENTION ADVANCES OUR RESEARCH". THERE IS LIMITED FUNDING FROM NIH AND THE AMERICAN CANCER SOCIETY AND THEREFOR JEFFERSON'S RESEARCH TEAM RELIES ON PHILANTHORPY TO CONTINUE TO CREATE FORWARD MOVEMENT IN TREATING THIS DISEASE.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Michael Tester President | OfficerTrustee | 1.5 | $0 |
Kristen Tester Secretary | OfficerTrustee | 1.5 | $0 |
Marissa Tester Treasurer | OfficerTrustee | 1.5 | $0 |
Annemarie Tester Board Member | Trustee | 1.5 | $0 |
William Tester Board Member | Trustee | 1.5 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $60,275 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $60,275 |
Total Program Service Revenue | $172,832 |
Investment income | $0 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $233,107 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $150,000 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $0 |
Compensation of current officers, directors, key employees. | $0 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $0 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $0 |
Payroll taxes | $0 |
Fees for services: Management | $0 |
Fees for services: Legal | $2,275 |
Fees for services: Accounting | $0 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $0 |
Advertising and promotion | $8,559 |
Office expenses | $0 |
Information technology | $0 |
Royalties | $0 |
Occupancy | $14,988 |
Travel | $0 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $0 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $0 |
Insurance | $2,201 |
All other expenses | $0 |
Total functional expenses | $224,610 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $8,497 |
Savings and temporary cash investments | $0 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $0 |
Net Land, buildings, and equipment | $0 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $8,497 |
Accounts payable and accrued expenses | $0 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $0 |
Net assets without donor restrictions | $8,497 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $8,497 |